Cannabis Bioscience delays annual report, $89K sales
Cannabis Bioscience International Holdings, Inc. (CBIH) reported that its Form 10‑K for the year ended May 31, 2026 will be filed late under Form 12b‑25 because the financial information cannot be analyzed and completed on a timely basis.
Rhea-AI Filing Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) reported that its Form 10‑K for the year ended May 31, 2026 will be filed late under Form 12b‑25 because the financial information cannot be analyzed and completed on a timely basis.
Based on preliminary estimates, loss from operations for 2026 is about $375,000, compared with $421,365 previously reported for the comparable period. Estimated 2026 revenue is about $89,000 and gross profit about $67,000, versus $303,022 and $262,916 a year earlier. Total operating expenses are estimated at $442,000, down from $684,281, mainly from lower contract labor, professional fees and rent, partially offset by higher officer compensation. The company notes these figures may change once the independent registered accounting firm completes its audit for the two-year period ended May 31, 2026.
Positive
- Estimated operating expenses fell to $442,000 from $684,281, with notable reductions in contract labor, professional fees and rent, contributing to a smaller operating loss.
- Estimated loss from operations narrowed to about $375,000 from $421,365, indicating lower negative operating performance year over year, based on preliminary figures.
Negative
- CBIH filed a Form 12b‑25, indicating its Form 10‑K for the year ended May 31, 2026 will be filed late.
- Estimated revenue dropped to about $89,000 from $303,022, and gross profit to about $67,000 from $262,916, indicating a substantial decline in sales activity.
- The company states that its independent registered accounting firm has not completed its audit for the two-year period ended May 31, 2026, so the preliminary results may change.
Filing Explained
The 15-day relief period is the key change; audited annual results remain pending and may differ from the estimates.
A Form 10-K is the audited annual report. CBIH reports that its report for the year ended
The company’s disclosed revenue, gross profit, operating expenses and loss figures are estimates, not final audited results, because its independent registered accounting firm had not completed the audit of the two-year period ended
The material next step is the completed audit and filing of the Form 10-K; that filing will determine whether the preliminary annual figures change.
Key Figures
Key Terms
Form 12b-25 regulatory
loss from operations financial
gross profit financial
operating expenses financial
independent registered accounting firm regulatory
FAQ
Why is CBIH filing its Form 10-K late?
What are CBIH's estimated revenues for the year ended May 31, 2026?
How did CBIH's estimated operating results change versus the prior year?
How did CBIH's operating expenses change in 2026?
Are CBIH's 2026 financial figures final?
AI-generated analysis. How Rhea-AI works. Not financial advice.